Skip to main content
SpringerLink
Log in

Ribavirin/sofosbuvir/sofosbuvir/velpatasvir

Failure to achieve sustained virological response in hepatitis-C: 5 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Tang Q, et al. Sofosbuvir-based therapies achieved satisfactory virological response in Chinese individuals with genotypes 3 and 6 infections: A real-world experience. Infection and Drug Resistance 14: 2297-2307, 21 Jun 2021. Available from: URL: https://www.dovepress.com/getfile.php?fileID=70764

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ribavirin/sofosbuvir/sofosbuvir/velpatasvir. Reactions Weekly 1871, 367 (2021). https://doi.org/10.1007/s40278-021-01886-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-01886-8

Search

Navigation